Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis New search for studies and content updated (no change to conclusions)
Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis New search for studies and content updated (no change to conclusions) is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Palivizumab for Prophylaxis Against Respiratory Syncytial Virus Infection in Children With Cystic Fibrosis New Search for Studies and Content Updated (no Change to Conclusions)." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435128/all/Palivizumab_for_prophylaxis_against_respiratory_syncytial_virus_infection_in_children_with_cystic_fibrosis_New_search_for_studies_and_content_updated__no_change_to_conclusions_. Accessed 06 July 2022.
Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis New search for studies and content updated (no change to conclusions). Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435128/all/Palivizumab_for_prophylaxis_against_respiratory_syncytial_virus_infection_in_children_with_cystic_fibrosis_New_search_for_studies_and_content_updated__no_change_to_conclusions_. Accessed July 6, 2022.
Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis New search for studies and content updated (no change to conclusions). In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/435128/all/Palivizumab_for_prophylaxis_against_respiratory_syncytial_virus_infection_in_children_with_cystic_fibrosis_New_search_for_studies_and_content_updated__no_change_to_conclusions_
Palivizumab for Prophylaxis Against Respiratory Syncytial Virus Infection in Children With Cystic Fibrosis New Search for Studies and Content Updated (no Change to Conclusions) [Internet]. In: Cochrane Abstracts. [cited 2022 July 06]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435128/all/Palivizumab_for_prophylaxis_against_respiratory_syncytial_virus_infection_in_children_with_cystic_fibrosis_New_search_for_studies_and_content_updated__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis New search for studies and content updated (no change to conclusions)
ID - 435128
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435128/all/Palivizumab_for_prophylaxis_against_respiratory_syncytial_virus_infection_in_children_with_cystic_fibrosis_New_search_for_studies_and_content_updated__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -